“As a member of NYC medical royalty, we are honored to have Dr. Rios-Datta join our growing New Jersey and New York City area practice.” — Faisal Siddiqi, M.D., FACC, RPhs, who serves as VSC’s medical director
CLIFTON, N.J. (PRWEB)
December 21, 2020
Vein Specialist Centers announced today that a pioneer for the ground-breaking treatment of spider veins has joined its multi-location practice.
Claudia Rios-Datta, M.D., RPhs will begin practicing today at VSC’s Great Neck, New York as well as Clifton and Paramus, New Jersey offices. Dr. Rios-Datta is a pioneer in cryo-sclerotherapy, which quickly turned spider vein treatments into pain-free, minimally invasive, outpatient procedures in 2000. As a result, the media crowned her the “Vein Queen” during its coverage of the breakthrough medical advancement.
“As a member of NYC medical royalty, we are honored to have Dr. Rios-Datta join our growing New Jersey and New York City area practice,” said Faisal Siddiqi, M.D., FACC, RPhs, who serves as VSC’s medical director, overseeing operations for eight locations throughout New Jersey. “Dr. Rios-Datta brings a wealth of cutting-edge knowledge in vein treatment that will enrich our network of board-certified physicians who continue to deliver a pain-free experience with immediate results.”
Claudia Rios-Datta, M.D., FAAC, RPhs
Dr. Rios-Datta is board certified in internal medicine. She is a member of the American Board of Venous & Lymphatic Medicine (ABVLM) and a Registered Phlebology Sonographer (RPhs). She received her medical degree from the Universidad Libre De Cali in Colombia and completed her internal medicine residency at Jacobi Medical Center—Albert Einstein School of Medicine.
In 2019, Dr. Rios joined the Hackett Hemwall Patterson Foundation on their vein treatment mission to Honduras, where she used her skills to provide critically needed medical care to the underserved. This experience gave Dr. Rios a deep understanding of the negative effects of venous disease that impacts the everyday life of her patients.
An Innovative, Multi-Specialty Approach
At VSC, a team of physicians has created a better way to treat spider veins and varicose veins. The group of doctors have developed a unique, multi-specialty approach, bringing together board-certified experts in vascular surgery and cardiovascular specialties to deliver a pain-free experience with immediate results.
The practice’s outstanding team of board-certified, Ivy League-trained physicians, which includes vascular surgeons and cardiovascular surgeons, have built a growing practice that truly puts patients’ needs first.
- VSC’s Ivy League-trained physicians change lives by providing pain-free, minimally invasive treatments, which produce immediate results that allow them to quickly recover.
- VSC is committed to spending time with every patient, ensuring that they answer all questions. Their attention to every detail has earned high satisfaction ratings in the Greater New York region for the practice.
- VSC’s spa-like facilities use the latest technology for successful outcomes, ranging from vein treatment to vein therapies.
At VSC, the entire staff takes pride in raising the quality of every patient’s life, so they can quickly resume their on-the-go, busy lifestyle.
To learn more about Vein Specialist Centers, visit the network of physicians.
About Vein Specialist Centers
Vein Specialist Centers specialize in minimally invasive therapies that produce pain-free, immediate, life-changing outcomes for active patients who suffer from disorders that include spider veins, varicose veins, restless leg syndrome, deep thrombosis and pelvic venous congestion. Our network of healthcare professionals, which includes our support staff, is patient-focused, ensuring that we are the standard bearer for excellence in patient care. Our board-certified physicians—Ivy League educated and trained—are committed to spending the necessary amount of time with our patients to properly treat them. We have offices throughout New Jersey. For more information, visit our website or call (609) 257-2095.
Share article on social media or email: